COMPOUNDS AND METHODS FOR THE TREATMENT OF CD20 POSITIVE DISEASES
- 专利权人:
- LTD.; CO.;BIO-THERA SOLUTIONS
- 发明人:
- Chao Qin,Shengfeng Li
- 申请号：
- US13834726
- 公开号：
- US20140178411A1
- 申请日:
- 2013.03.15
- 申请国别(地区):
- US
- 年份:
- 2014
- 代理人:
- 摘要：
- Disclosed herein are anti-CD20 antibody conjugated with maytansinoid drugs for targeted delivery to disease tissues. Methods related to the preparation and uses of such antibody drug conjugates to treat CD20 positive cells in cancers are provided.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Type II anti-CD20 antibody for reducing formation of anti-drug antibodies
- Use of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) in combination with cyclophosphamide, vincristine and doxorubicine for preparation of medicaments for treating non-hodgkins lymphomas
- Method for reducing the formation of anti Drug (ADA) and method of treating a proliferative disorder of B Cells
- COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXITY (ADCC)
- COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXITY (ADCC)
